GO
Loading...

Acorda CEO: Medications More Economical Down the Road

Wednesday, 9 Jan 2013 | 6:15 PM ET

Acorda Therapeutics CEO Dr. Ron Cohen discusses the phase 2 studies happening on its mobility improvement drug Ampyra, and what's next for the company.